These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 455177)

  • 21. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory quality regulations and accreditation standards in Canada.
    Li H; Adeli K
    Clin Biochem; 2009 Mar; 42(4-5):249-55. PubMed ID: 19863915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portability of licensure in Canada based on accreditation and certification.
    Gerrow JD; Boyd MA; Scott DA
    J Am Coll Dent; 2003; 70(1):8-10. PubMed ID: 12772766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accredited dental schools. Commission on Dental Accreditation.
    J Am Dent Assoc; 1990 Nov; 121(5):649-50, 652. PubMed ID: 2229746
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
    Matthews JH
    Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Institution/investigator-initiated clinical trials in Canada.
    Sedgeworth J; Derewlany L
    Can J Clin Pharmacol; 2006; 13(2):e236-9. PubMed ID: 16873897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmaceuticals: a strategic national industry].
    Hollender L
    Bull Acad Natl Med; 2004; 188(4):701-13. PubMed ID: 15587688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug samples: friend or foe?
    Coolidge MP
    J Drugs Dermatol; 2002 Jul; 1(1):49-52. PubMed ID: 12847754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmaceutical industry in Canada?
    Wigle WW
    Can Med Assoc J; 1967 Nov; 97(22):1361. PubMed ID: 6061604
    [No Abstract]   [Full Text] [Related]  

  • 33. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timeliness of receipt of manufacturers' new product information.
    Murdoch LA; Lum L
    Can J Hosp Pharm; 1991 Oct; 44(5):235-8. PubMed ID: 10115576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
    Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
    Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between pharmaceutical company user fees and drug approvals in Canada and Australia: a hypothesis-generating study.
    Lexchin J
    Ann Pharmacother; 2006 Dec; 40(12):2216-22. PubMed ID: 17132811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives.
    Clauson KA; Khanfar NM; Polen HH; Gibson F
    J Clin Nurs; 2009 Jan; 18(2):228-33. PubMed ID: 19120751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of the National Dental Examining Board of Canada written examination and implications for certification.
    Gerrow JD; Boyd MA; Duquette P; Bentley KC
    J Dent Educ; 1997 Dec; 61(12):921-7. PubMed ID: 9457133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. After years of steady growth, winds of restraint blowing on prescription-drug industry.
    Robinson A
    CMAJ; 1995 Jul; 153(1):85-8. PubMed ID: 7796380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accredited pharmacy residency programs in Canada and roster of pharmacy residents 1976-77 compiled by the Canadian Hospital Pharmacy Residency Board.
    Can J Hosp Pharm; 1976; 29(5):162-3. PubMed ID: 801129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.